Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 10617 - 10624 of 12007 results

Notice to Plans and PBMs: Pay for Contraceptive Services and Maybe We Will Pay You Back

February 18, 2014| Blog| Viewpoint

FTC Approves Another COPPA Safe Harbor Program

February 18, 2014| Blog| Viewpoint

The Affordable Care Act—Countdown to Compliance for Employers, Week 45: Focus on the Transition Rules under Final Treasury/IRS Regulations Implementing the Affordable Care Act’s Employer Shared Responsibility Rules

February 18, 2014| Blog| Viewpoint

Employers Should File Their H-1B Visa Petitions by April 1st, 2014

February 18, 2014| Blog| Viewpoint

NLRB and Wal-Mart Face Off Over Strikes

February 18, 2014| Blog| Viewpoint

New Payment Card Technology Finally Coming to US? Target Takes the Lead

February 14, 2014| Blog| Viewpoint

Some Valentine's Day Reading for Employers Trying to Manage Workplace Romances

February 14, 2014| Blog| Viewpoint

NIST Framework for Critical Infrastructure Released

February 13, 2014| Blog| Viewpoint

News & Press Releases

Mintz Advises ArriVent BioPharma on $75 Million Underwritten Public Offering

July 08, 2025

Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“

Mintz Advises S2G Investments on $40M Series B Financing of Sojo Industries

July 07, 2025

Mintz represented S2G Investments, a multi-stage investment firm focused on venture and growth-stage businesses across food & agriculture, oceans and energy, in its $40 million Series B financing of Sojo Industries, an industrial automation company that utilizes robotics, mobility, and software to deliver packaging and assembly solutions to the food and beverage industry.

Mintz Advises Syntis Bio on $33 Million Series A Financing

July 02, 2025

Mintz advised Syntis Bio, a clinical-stage biopharmaceutical company revolutionizing oral therapies for obesity, diabetes, and rare diseases, on a $33 million oversubscribed Series A financing.

View all News and Press Releases